Immunotherapy - PDFSEARCH.IO - Document Search Engine

Immunotherapy
Results: 985

#	Item
491	Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or Add to Reading List Source URL: www.fda.gov Language: English Amines Pixantrone Quinones Mitoxantrone Immunotherapy Rituximab Medicine Chemistry Organic chemistry
492	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 13 and 14, 2011 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-11-26 15:30:52 Oncology Genes Transcription factors Brachyury Embryology Gene therapy Carcinogenesis Metastasis Immunotherapy Medicine Biology Biotechnology
493	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Brentjens/Sadelain Memorial Sloan Kettering Cancer Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:08 T cells Lymphoma Immunology Mantle cell lymphoma B-cell chronic lymphocytic leukemia Chimeric antigen receptor Immunotherapy Hematopoietic stem cell transplantation Cancer immunotherapy Medicine Lymphocytic leukemia Immune system
494	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:32:16 CD20 Immunotherapy Cancer immunotherapy Ofatumumab Medicine Lymphoma Mantle cell lymphoma
495	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:16:28 Immunology Cancer treatments Lymphoma Immunotherapy B-cell chronic lymphocytic leukemia Melanoma Cancer immunotherapy Chimeric antigen receptor Lymphocyte Medicine Immune system T cells
496	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:16:07 Cancer treatments Immune system T cells Gynaecological cancer Ovarian cancer Immunotherapy Cancer immunotherapy Medicine Anatomy Immunology
497	EVOLUTION OF TRIAL DESIGN USING GENE-MODIFIED T CELLS Richard P Junghans, PhD, MD Director, Biotherapeutics Development Lab Associate Professor of Surgery and Medicine Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 13:16:00 Biology Immune system Lymphocyte Immunology Melanoma Antigen Tumor antigen Immunotherapy Anatomy Medicine T cells
498	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:31:58 Biology HER2/neu Chimeric antigen receptor Immunology Cancer immunotherapy CD28 Immunotherapy CD3 Cytotoxic T cell Immune system Anatomy T cells
499	Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:15:20 Immunotherapy Pancytopenia Melanoma Metastasis Medicine T cells Immunology
500	T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Richard P Junghans, PhD, MD Roger Williams Medical Center Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:16:13 Molecular biology Prostate cancer Retrovirus Prostate-specific membrane antigen Immunotherapy Cancer immunotherapy Neuroblastoma Lentivirus Medicine Oncology Immune system

UPDATE